Genta, S.; Ghilardi, G.; Cascione, L.; Juskevicius, D.; Tzankov, A.; Schär, S.; Milan, L.; Pirosa, M.C.; Esposito, F.; Ruberto, T.;
et al. Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers 2022, 14, 1018.
https://doi.org/10.3390/cancers14041018
AMA Style
Genta S, Ghilardi G, Cascione L, Juskevicius D, Tzankov A, Schär S, Milan L, Pirosa MC, Esposito F, Ruberto T,
et al. Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers. 2022; 14(4):1018.
https://doi.org/10.3390/cancers14041018
Chicago/Turabian Style
Genta, Sofia, Guido Ghilardi, Luciano Cascione, Darius Juskevicius, Alexandar Tzankov, Sämi Schär, Lisa Milan, Maria Cristina Pirosa, Fabiana Esposito, Teresa Ruberto,
and et al. 2022. "Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study" Cancers 14, no. 4: 1018.
https://doi.org/10.3390/cancers14041018
APA Style
Genta, S., Ghilardi, G., Cascione, L., Juskevicius, D., Tzankov, A., Schär, S., Milan, L., Pirosa, M. C., Esposito, F., Ruberto, T., Giovanella, L., Hayoz, S., Mamot, C., Dirnhofer, S., Zucca, E., & Ceriani, L.
(2022). Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers, 14(4), 1018.
https://doi.org/10.3390/cancers14041018
